Omega Therapeutics is a clinical-stage biotechnology company based in Kingwood, TX, specializing in the development of programmable epigenomic mRNA medicines. Their innovative OMEGA platform combines computational genomics, machine learning, and artificial intelligence to design customized therapeutics that control gene expression and cellular programming, with the aim of treating a wide range of diseases.
With a robust pipeline targeting diverse biology, tissue, and disease types, Omega Therapeutics is committed to addressing unmet patient needs. Their world-class team of leaders, thinkers, and scientists is dedicated to the discovery and development of groundbreaking therapeutics, guided by an ambitious yet humble ethos.
Generated from the website